Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2019 Filed Feb 9, 2019 00:37 UTC |
Albright CharlesChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 8,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001684 · edgar.xml · derivative · entry 2 Albright Charles · CIK 0001682323 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,125 Underlying: Common Stock · 8,125 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc. F3 · derivative.exercise_date: The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest. F3 · derivative.expiration_date: The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest. Read SEC document |
| February 06, 2019 Filed Feb 9, 2019 00:37 UTC |
Albright CharlesChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 48,750 | $0.00 Strike: $21.10 | $0.00 |
DisclosureSEC source: 0001179110-19-001684 · edgar.xml · derivative · entry 1 Albright Charles · CIK 0001682323 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,750 Underlying: Common Stock · 48,750 shares Expires 2029-02-05 F1 · derivative.exercise_date: This option was granted on February 6, 2019 and is scheduled to vest over four years in equal monthly installments beginning on February 6, 2019 through February 6, 2023. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:41 UTC |
Scadden DavidDirector
|
GrantStock Option (right to buy) · Derivative | 23,076 | $0.00 Strike: $21.14 | $0.00 |
DisclosureSEC source: 0001179110-19-001519 · edgar.xml · derivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,076 Underlying: Common Stock · 23,076 shares Expires 2029-02-04 F1 · derivative.exercise_date: This option was granted on February 5, 2019 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on February 5, 2020 through February 5, 2022. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:41 UTC |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,895 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001179110-19-001436 · edgar.xml · derivative · entry 3 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,618 Underlying: Common Stock · 6,895 shares Expires 2025-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 28, 2018. F3 · derivative.exercise_date: This option was granted on September 14, 2015 and is scheduled to vest over four years with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:41 UTC |
Hack Andrew A. F.Chief Financial Officer
|
SaleCommon Stock | 6,895 | $21.39 | $147,484.05 |
DisclosureSEC source: 0001179110-19-001436 · edgar.xml · nonDerivative · entry 2 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 28, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.16 to $21.805. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:41 UTC |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionCommon Stock | 6,895 | $6.48 | $44,679.60 |
DisclosureSEC source: 0001179110-19-001436 · edgar.xml · nonDerivative · entry 1 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 28, 2018. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 22:36 UTC |
Collins CynthiaDirector
|
GrantRestricted Stock Units · Derivative | 8,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001239 · edgar.xml · derivative · entry 1 Collins Cynthia · CIK 0001405692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,283 Underlying: Common Stock · 8,283 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc. F2 · derivative.exercise_date: The restricted stock unit award is scheduled to vest in its entirety on the earlier of (i) July 31, 2019, (ii) the appointment by the Board of Directors of Editas Medicine, Inc. (the "Company") of a permanent chief executive officer or (iii) the termination of a consulting agreement entered into by the Reporting Person and the Company (the "Trigger Date"). On the Trigger Date, all shares will be delivered to the Reporting Person. F2 · derivative.expiration_date: The restricted stock unit award is scheduled to vest in its entirety on the earlier of (i) July 31, 2019, (ii) the appointment by the Board of Directors of Editas Medicine, Inc. (the "Company") of a permanent chief executive officer or (iii) the termination of a consulting agreement entered into by the Reporting Person and the Company (the "Trigger Date"). On the Trigger Date, all shares will be delivered to the Reporting Person. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 22:29 UTC |
Albright CharlesChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 17,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001235 · edgar.xml · derivative · entry 1 Albright Charles · CIK 0001682323 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,977 Underlying: Common Stock · 17,977 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc. F2 · derivative.exercise_date: The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020. F2 · derivative.expiration_date: The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 22:32 UTC |
Myer VickeshChief Technology Officer
|
GrantRestricted Stock Units · Derivative | 16,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001237 · edgar.xml · derivative · entry 1 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,722 Underlying: Common Stock · 16,722 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc. F2 · derivative.exercise_date: The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020. F2 · derivative.expiration_date: The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020. Read SEC document |
| January 18, 2019 Filed Jan 19, 2019 01:58 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $11.21 | $0.00 |
DisclosureSEC source: 0001104659-19-002543 · a4.xml · derivative · entry 6 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,897 Underlying: Common Stock · 4,000 shares Expires 2025-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F4 · derivative.exercise_date: This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019. Read SEC document |
| January 18, 2019 Filed Jan 19, 2019 01:58 UTC |
Myer VickeshChief Technology Officer
|
SaleCommon Stock | 4,000 | $26.50 | $106,000.00 |
DisclosureSEC source: 0001104659-19-002543 · a4.xml · nonDerivative · entry 4 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| January 18, 2019 Filed Jan 19, 2019 01:58 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionCommon Stock | 4,000 | $11.21 | $44,840.00 |
DisclosureSEC source: 0001104659-19-002543 · a4.xml · nonDerivative · entry 3 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| January 17, 2019 Filed Jan 19, 2019 01:58 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001104659-19-002543 · a4.xml · derivative · entry 5 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,307 Underlying: Common Stock · 3,000 shares Expires 2025-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F3 · derivative.exercise_date: This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019. Read SEC document |
| January 17, 2019 Filed Jan 19, 2019 01:58 UTC |
Myer VickeshChief Technology Officer
|
SaleCommon Stock | 3,000 | $26.18 | $78,540.00 |
DisclosureSEC source: 0001104659-19-002543 · a4.xml · nonDerivative · entry 2 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.03 to $26.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| January 17, 2019 Filed Jan 19, 2019 01:58 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionCommon Stock | 3,000 | $0.65 | $1,950.00 |
DisclosureSEC source: 0001104659-19-002543 · a4.xml · nonDerivative · entry 1 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 16:11 UTC |
Bosley KatrineDirector · President and CEO
|
SaleCommon Stock | 12,000 | $25.27 | $303,240.00 |
DisclosureSEC source: 0001179110-19-000653 · edgar.xml · nonDerivative · entry 1 Bosley Katrine · CIK 0001592469 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204,966 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.83. The price reported above reflected the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 22:36 UTC |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001179110-19-000578 · edgar.xml · derivative · entry 3 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,513 Underlying: Common Stock · 7,000 shares Expires 2025-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. F3 · derivative.exercise_date: This option was granted on September 14, 2015 and is scheduled to vest over four years with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 22:36 UTC |
Hack Andrew A. F.Chief Financial Officer
|
SaleCommon Stock | 7,000 | $22.48 | $157,360.00 |
DisclosureSEC source: 0001179110-19-000578 · edgar.xml · nonDerivative · entry 2 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.08 to $22.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 22:36 UTC |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,000 | $6.48 | $45,360.00 |
DisclosureSEC source: 0001179110-19-000578 · edgar.xml · nonDerivative · entry 1 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 21:41 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $11.21 | $0.00 |
DisclosureSEC source: 0001179110-18-014142 · edgar.xml · derivative · entry 7 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,897 Underlying: Common Stock · 4,000 shares Expires 2025-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F6 · derivative.exercise_date: This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 21:41 UTC |
Myer VickeshChief Technology Officer
|
SaleCommon Stock | 4,000 | $27.41 | $109,640.00 |
DisclosureSEC source: 0001179110-18-014142 · edgar.xml · nonDerivative · entry 5 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $27.16 to $27.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 21:41 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionCommon Stock | 4,000 | $11.21 | $44,840.00 |
DisclosureSEC source: 0001179110-18-014142 · edgar.xml · nonDerivative · entry 4 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:41 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001179110-18-014142 · edgar.xml · derivative · entry 6 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,307 Underlying: Common Stock · 3,000 shares Expires 2025-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F5 · derivative.exercise_date: This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:41 UTC |
Myer VickeshChief Technology Officer
|
SaleCommon Stock | 700 | $28.34 | $19,838.00 |
DisclosureSEC source: 0001179110-18-014142 · edgar.xml · nonDerivative · entry 3 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $28.22 to $28.53. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:41 UTC |
Myer VickeshChief Technology Officer
|
SaleCommon Stock | 2,300 | $27.75 | $63,825.00 |
DisclosureSEC source: 0001179110-18-014142 · edgar.xml · nonDerivative · entry 2 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $27.22 to $28.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:41 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionCommon Stock | 3,000 | $0.65 | $1,950.00 |
DisclosureSEC source: 0001179110-18-014142 · edgar.xml · nonDerivative · entry 1 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 14:14 UTC |
Collins CynthiaDirector
|
GrantStock Option (right to buy) · Derivative | 23,076 | $0.00 Strike: $29.69 | $0.00 |
DisclosureSEC source: 0001179110-18-013609 · edgar.xml · derivative · entry 1 Collins Cynthia · CIK 0001405692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,076 Underlying: Common Stock · 23,076 shares Expires 2028-12-05 F1 · derivative.exercise_date: This option was granted on December 6, 2018 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on December 6, 2019 through December 6, 2021. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 16:02 UTC |
Bosley KatrineDirector · President and CEO
|
SaleCommon Stock | 100 | $32.39 | $3,239.00 |
DisclosureSEC source: 0001179110-18-013511 · edgar.xml · nonDerivative · entry 2 Bosley Katrine · CIK 0001592469 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,216,966 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 16:02 UTC |
Bosley KatrineDirector · President and CEO
|
SaleCommon Stock | 11,900 | $31.92 | $379,848.00 |
DisclosureSEC source: 0001179110-18-013511 · edgar.xml · nonDerivative · entry 1 Bosley Katrine · CIK 0001592469 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217,066 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.36 to $32.28. The price reported above reflected the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 23, 2018 Filed Nov 27, 2018 21:25 UTC |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,284 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001179110-18-013245 · edgar.xml · derivative · entry 4 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,229 Underlying: Common Stock · 5,284 shares Expires 2025-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. F3 · derivative.exercise_date: This option was granted on September 14, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019. Read SEC document |
| November 23, 2018 Filed Nov 27, 2018 21:25 UTC |
Hack Andrew A. F.Chief Financial Officer
|
SaleCommon Stock | 100 | $28.61 | $2,861.00 |
DisclosureSEC source: 0001179110-18-013245 · edgar.xml · nonDerivative · entry 3 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. Read SEC document |
| November 23, 2018 Filed Nov 27, 2018 21:25 UTC |
Hack Andrew A. F.Chief Financial Officer
|
SaleCommon Stock | 5,184 | $28.14 | $145,877.76 |
DisclosureSEC source: 0001179110-18-013245 · edgar.xml · nonDerivative · entry 2 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $27.48 to $28.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected Read SEC document |
| November 23, 2018 Filed Nov 27, 2018 21:25 UTC |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,284 | $6.48 | $34,240.32 |
DisclosureSEC source: 0001179110-18-013245 · edgar.xml · nonDerivative · entry 1 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. Read SEC document |
| November 23, 2018 Filed Jan 8, 2019 22:34 UTC Amendment |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,284 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001179110-19-000576 · edgar.xml · derivative · entry 2 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,143 Underlying: Common Stock · 5,284 shares Expires 2025-07-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person is filing this amended Form 4 to amend the Form 4 filed by the Reporting Person with the SEC on November 27, 2018, which inadvertently reported the exercise of a different stock option held by the Reporting Person. This amended Form 4 now reflects the correct information regarding the option that was exercised. F2 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. F3 · derivative.exercise_date: This option was granted on July 14, 2015 and is scheduled to vest over four years with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019. Read SEC document |
| November 23, 2018 Filed Jan 8, 2019 22:34 UTC Amendment |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,284 | $3.23 | $17,067.32 |
DisclosureSEC source: 0001179110-19-000576 · edgar.xml · nonDerivative · entry 1 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person is filing this amended Form 4 to amend the Form 4 filed by the Reporting Person with the SEC on November 27, 2018, which inadvertently reported the exercise of a different stock option held by the Reporting Person. This amended Form 4 now reflects the correct information regarding the option that was exercised. F2 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 21:03 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $11.21 | $0.00 |
DisclosureSEC source: 0001179110-18-013070 · edgar.xml · derivative · entry 8 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,897 Underlying: Common Stock · 4,000 shares Expires 2025-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F5 · derivative.exercise_date: This option was granted on October 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on October 27, 2016 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 27, 2019. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 21:03 UTC |
Myer VickeshChief Technology Officer
|
SaleCommon Stock | 4,000 | $26.50 | $106,000.00 |
DisclosureSEC source: 0001179110-18-013070 · edgar.xml · nonDerivative · entry 6 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 21:03 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionCommon Stock | 4,000 | $11.21 | $44,840.00 |
DisclosureSEC source: 0001179110-18-013070 · edgar.xml · nonDerivative · entry 5 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:03 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001179110-18-013070 · edgar.xml · derivative · entry 7 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,307 Underlying: Common Stock · 3,000 shares Expires 2025-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F4 · derivative.exercise_date: This option was granted on April 30, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on April 21, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through April 21, 2019. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:03 UTC |
Myer VickeshChief Technology Officer
|
SaleCommon Stock | 300 | $28.85 | $8,655.00 |
DisclosureSEC source: 0001179110-18-013070 · edgar.xml · nonDerivative · entry 4 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $28.82 to $28.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:03 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionCommon Stock | 300 | $0.65 | $195.00 |
DisclosureSEC source: 0001179110-18-013070 · edgar.xml · nonDerivative · entry 3 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:03 UTC |
Myer VickeshChief Technology Officer
|
SaleCommon Stock | 2,700 | $28.12 | $75,924.00 |
DisclosureSEC source: 0001179110-18-013070 · edgar.xml · nonDerivative · entry 2 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $27.73 to $28.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:03 UTC |
Myer VickeshChief Technology Officer
|
Exercise / conversionCommon Stock | 2,700 | $0.65 | $1,755.00 |
DisclosureSEC source: 0001179110-18-013070 · edgar.xml · nonDerivative · entry 1 Myer Vickesh · CIK 0001742806 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2017. Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 17:42 UTC |
Bosley KatrineDirector · President and CEO
|
SaleCommon Stock | 8,600 | $27.21 | $234,006.00 |
DisclosureSEC source: 0001179110-18-012584 · edgar.xml · nonDerivative · entry 2 Bosley Katrine · CIK 0001592469 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228,966 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended. F3 · price: This transaction was executed in multiple trades at prices ranging from $26.57 to $27.52. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 17:42 UTC |
Bosley KatrineDirector · President and CEO
|
SaleCommon Stock | 3,400 | $26.03 | $88,502.00 |
DisclosureSEC source: 0001179110-18-012584 · edgar.xml · nonDerivative · entry 1 Bosley Katrine · CIK 0001592469 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,237,566 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.49 to $26.44. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 26, 2018 Filed Oct 30, 2018 21:05 UTC |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001179110-18-012390 · edgar.xml · derivative · entry 3 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,513 Underlying: Common Stock · 6,000 shares Expires 2025-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. F3 · derivative.exercise_date: This option was granted on September 14, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019. Read SEC document |
| October 26, 2018 Filed Oct 30, 2018 21:05 UTC |
Hack Andrew A. F.Chief Financial Officer
|
SaleCommon Stock | 6,000 | $25.70 | $154,200.00 |
DisclosureSEC source: 0001179110-18-012390 · edgar.xml · nonDerivative · entry 2 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.20 to $26.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 26, 2018 Filed Oct 30, 2018 21:05 UTC |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionCommon Stock | 6,000 | $6.48 | $38,880.00 |
DisclosureSEC source: 0001179110-18-012390 · edgar.xml · nonDerivative · entry 1 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. Read SEC document |
| October 26, 2018 Filed Jan 8, 2019 22:32 UTC Amendment |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001179110-19-000574 · edgar.xml · derivative · entry 2 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,427 Underlying: Common Stock · 6,000 shares Expires 2025-07-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person is filing this amended Form 4 to amend the Form 4 filed by the Reporting Person with the SEC on October 30, 2018, which inadvertently reported the exercise of a different stock option held by the Reporting Person. This amended Form 4 now reflects the correct information regarding the option that was exercised. F2 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. F3 · derivative.exercise_date: This option was granted on July 14, 2015 and is scheduled to vest over four years with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019. Read SEC document |
| October 26, 2018 Filed Jan 8, 2019 22:32 UTC Amendment |
Hack Andrew A. F.Chief Financial Officer
|
Exercise / conversionCommon Stock | 6,000 | $3.23 | $19,380.00 |
DisclosureSEC source: 0001179110-19-000574 · edgar.xml · nonDerivative · entry 1 Hack Andrew A. F. · CIK 0001657434 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person is filing this amended Form 4 to amend the Form 4 filed by the Reporting Person with the SEC on October 30, 2018, which inadvertently reported the exercise of a different stock option held by the Reporting Person. This amended Form 4 now reflects the correct information regarding the option that was exercised. F2 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.